Skip to main content
. 2018 Mar 25;9(5):606–612. doi: 10.1111/1759-7714.12626

Figure 6.

Figure 6

Forest plot of one‐year survival rate for Endostar versus placebo in combination with vinorelbine plus cisplatin chemotherapy regimen in treatment of advanced non‐small cell lung cancer. CI, confidence interval.